{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:08:29Z","timestamp":1792066109865,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0074"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0074"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00428-025-04111-8","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:41:24Z","timestamp":1746171684000},"page":"377-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinicopathological and molecular features of so-called low-grade oncocytic fumarate hydratase\u2013deficient renal cell carcinoma: a study of 5 cases"],"prefix":"10.1007","volume":"487","author":[{"given":"Bin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2222-5687","authenticated-orcid":false,"given":"Kuo","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"4111_CR1","volume-title":"Urinary and male genital tumours [Internet]","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board (2022) Urinary and male genital tumours [Internet], 5th edn. International Agency for Research on Cancer, Lyon (France)","edition":"5"},{"key":"4111_CR2","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","volume":"31","author":"MJ Merino","year":"2007","unstructured":"Merino MJ, Torres-Cabala C, Pinto P, Marston Linehan W (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578\u20131585. https:\/\/doi.org\/10.1097\/PAS.0b013e31804375b8","journal-title":"Am J Surg Pathol"},{"key":"4111_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","volume":"38","author":"Y-B Chen","year":"2014","unstructured":"Chen Y-B, Brannon AR, Toubaji A et al (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome\u2013associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol 38:627\u2013637. https:\/\/doi.org\/10.1097\/PAS.0000000000000163","journal-title":"Am J Surg Pathol"},{"key":"4111_CR4","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","volume":"40","author":"SC Smith","year":"2016","unstructured":"Smith SC, Trpkov K, Chen Y-B et al (2016) Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol 40:1457\u20131472. https:\/\/doi.org\/10.1097\/PAS.0000000000000719","journal-title":"Am J Surg Pathol"},{"key":"4111_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/PAS.0000000000001000","volume":"42","author":"C Ohe","year":"2018","unstructured":"Ohe C, Smith SC, Sirohi D et al (2018) Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase\u2013deficient renal cell carcinoma. Am J Surg Pathol 42:279\u2013292. https:\/\/doi.org\/10.1097\/PAS.0000000000001000","journal-title":"Am J Surg Pathol"},{"key":"4111_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","volume":"44","author":"HD Lau","year":"2020","unstructured":"Lau HD, Chan E, Fan AC et al (2020) A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients. Am J Surg Pathol 44:98\u2013110. https:\/\/doi.org\/10.1097\/PAS.0000000000001372","journal-title":"Am J Surg Pathol"},{"key":"4111_CR7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/jclinpath-2019-205924","volume":"72","author":"X Pan","year":"2019","unstructured":"Pan X, Zhang M, Yao J et al (2019) Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases. J Clin Pathol 72:748\u2013754. https:\/\/doi.org\/10.1136\/jclinpath-2019-205924","journal-title":"J Clin Pathol"},{"key":"4111_CR8","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.5858\/arpa.2023-0330-OA","volume":"148","author":"X Yang","year":"2024","unstructured":"Yang X, Liu Y, Wang H et al (2024) Fumarate hydratase\u2013deficient renal cell carcinoma with predominant tubulocystic features mimics tubulocystic renal cell carcinoma. Arch Pathol Lab Med 148:1358\u20131364. https:\/\/doi.org\/10.5858\/arpa.2023-0330-OA","journal-title":"Arch Pathol Lab Med"},{"key":"4111_CR9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"M Muller","year":"2018","unstructured":"Muller M, Guillaud-Bataille M, Salleron J et al (2018) Pattern multiplicity and fumarate hydratase (FH)\/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration. Mod Pathol 31:974\u2013983. https:\/\/doi.org\/10.1038\/s41379-018-0017-7","journal-title":"Mod Pathol"},{"key":"4111_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/his.13183","volume":"71","author":"SC Smith","year":"2017","unstructured":"Smith SC, Sirohi D, Ohe C et al (2017) A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma. Histopathology 71:42\u201352. https:\/\/doi.org\/10.1111\/his.13183","journal-title":"Histopathology"},{"key":"4111_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/his.13395","volume":"72","author":"Y Li","year":"2018","unstructured":"Li Y, Reuter VE, Matoso A et al (2018) Re-evaluation of 33 \u2018unclassified\u2019 eosinophilic renal cell carcinomas in young patients. Histopathology 72:588\u2013600. https:\/\/doi.org\/10.1111\/his.13395","journal-title":"Histopathology"},{"key":"4111_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","volume":"91","author":"S Gupta","year":"2019","unstructured":"Gupta S, Swanson AA, Chen Y-B et al (2019) Incidence of succinate dehydrogenase and fumarate hydratase\u2013deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC. Hum Pathol 91:114\u2013122. https:\/\/doi.org\/10.1016\/j.humpath.2019.07.004","journal-title":"Hum Pathol"},{"key":"4111_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/PAP.0000000000000321","volume":"28","author":"A Hamza","year":"2021","unstructured":"Hamza A, Sirohi D, Smith SC, Amin MB (2021) Low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: an update on biologic potential, morphologic spectrum, and differential diagnosis with other low-grade oncocytic tumors. Adv Anat Pathol 28:396\u2013407. https:\/\/doi.org\/10.1097\/PAP.0000000000000321","journal-title":"Adv Anat Pathol"},{"key":"4111_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/10668969211026241","volume":"30","author":"N Wyvekens","year":"2022","unstructured":"Wyvekens N, Anderson WJ, Kim YX et al (2022) Low-grade fumarate hydratase-deficient renal cell carcinoma in a 30-year-old female. Int J Surg Pathol 30:184\u2013189. https:\/\/doi.org\/10.1177\/10668969211026241","journal-title":"Int J Surg Pathol"},{"key":"4111_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00428-018-2420-3","volume":"473","author":"IW Da Cunha","year":"2018","unstructured":"Da Cunha IW, Da Costa WH, Morini MA et al (2018) Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation. Virchows Arch 473:775\u2013779. https:\/\/doi.org\/10.1007\/s00428-018-2420-3","journal-title":"Virchows Arch"},{"key":"4111_CR16","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J (2018) fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884\u2013i890. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560","journal-title":"Bioinformatics"},{"key":"4111_CR17","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1002\/imt2.107","volume":"2","author":"S Chen","year":"2023","unstructured":"Chen S (2023) Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. Imeta 2:e107. https:\/\/doi.org\/10.1002\/imt2.107","journal-title":"Imeta"},{"key":"4111_CR18","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324","journal-title":"Bioinformatics"},{"key":"4111_CR19","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A et al (2009) The sequence alignment\/map format and SAMtools. Bioinformatics 25:2078\u20132079. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352","journal-title":"Bioinformatics"},{"key":"4111_CR20","unstructured":"Van der Auwera GA, O\u2019Connor BD (2020) Genomics in the cloud: Using Docker, GATK, and WDL in Terra, 1st Edition. O\u2019Reilly Media, Inc."},{"key":"4111_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE et al (2016) The Ensembl Variant Effect Predictor. Genome Biol 17:122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4","journal-title":"Genome Biol"},{"key":"4111_CR22","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M et al (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44:D862\u2013D868. https:\/\/doi.org\/10.1093\/nar\/gkv1222","journal-title":"Nucleic Acids Res"},{"key":"4111_CR23","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC (2016) CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol 12:e1004873. https:\/\/doi.org\/10.1371\/journal.pcbi.1004873","journal-title":"PLoS Comput Biol"},{"key":"4111_CR24","unstructured":"Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/21081509\/. Accessed 21 Dec 2024"},{"key":"4111_CR25","unstructured":"Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/22155870\/. Accessed 21 Dec 2024"},{"key":"4111_CR26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1097\/PAS.0000000000000520","volume":"39","author":"NM Joseph","year":"2015","unstructured":"Joseph NM, Solomon DA, Frizzell N et al (2015) Morphology and immunohistochemistry for 2SC and FH aid in detection of fumarate hydratase gene aberrations in uterine leiomyomas from young patients. Am J Surg Pathol 39:1529\u20131539. https:\/\/doi.org\/10.1097\/PAS.0000000000000520","journal-title":"Am J Surg Pathol"},{"key":"4111_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/pro.5560060410","volume":"6","author":"T Weaver","year":"1997","unstructured":"Weaver T, Lees M, Banaszak L (1997) Mutations of fumarase that distinguish between the active site and a nearby dicarboxylic acid binding site. Protein Sci 6:834\u2013842. https:\/\/doi.org\/10.1002\/pro.5560060410","journal-title":"Protein Sci"},{"key":"4111_CR28","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/10668969231195072","volume":"32","author":"H Wen","year":"2024","unstructured":"Wen H, Zheng L, Zhang M et al (2024) A rare case of synchronous fumarate hydratase-deficient renal cell carcinoma and clear cell renal cell carcinoma with fumarate hydratase and von Hippel-Lindau gene mutations: a clinicopathologic and molecular study. Int J Surg Pathol 32:810\u2013816. https:\/\/doi.org\/10.1177\/10668969231195072","journal-title":"Int J Surg Pathol"},{"key":"4111_CR29","doi-asserted-by":"publisher","first-page":"100303","DOI":"10.1016\/j.modpat.2023.100303","volume":"36","author":"L Zheng","year":"2023","unstructured":"Zheng L, Zhang X, Pan X et al (2023) AKR1B10 is a new sensitive and specific marker for fumarate hydratase-deficient renal cell carcinoma. Mod Pathol 36:100303. https:\/\/doi.org\/10.1016\/j.modpat.2023.100303","journal-title":"Mod Pathol"},{"key":"4111_CR30","doi-asserted-by":"publisher","unstructured":"Feng H, Cao S, Ouyang Q, et al (2023) Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma. Transl Androl Urol 12:308\u2013319. https:\/\/doi.org\/10.21037\/tau-23-32","DOI":"10.21037\/tau-23-32"},{"key":"4111_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/cge.13014","volume":"92","author":"M Muller","year":"2017","unstructured":"Muller M, Ferlicot S, Guillaud-Bataille M et al (2017) Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clin Genet 92:606\u2013615. https:\/\/doi.org\/10.1111\/cge.13014","journal-title":"Clin Genet"},{"key":"4111_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/PAT.0b013e328353bf5a","volume":"44","author":"R Arora","year":"2012","unstructured":"Arora R, Eble JN, Pierce HH et al (2012) Bilateral ovarian steroid cell tumours and massive macronodular adrenocortical disease in a patient with hereditary leiomyomatosis and renal cell cancer syndrome. Pathology 44:360\u2013363. https:\/\/doi.org\/10.1097\/PAT.0b013e328353bf5a","journal-title":"Pathology"},{"key":"4111_CR33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10545-011-9294-8","volume":"34","author":"S Picaud","year":"2011","unstructured":"Picaud S, Kavanagh KL, Yue WW et al (2011) Structural basis of fumarate hydratase deficiency. J Inherit Metab Dis 34:671\u2013676. https:\/\/doi.org\/10.1007\/s10545-011-9294-8","journal-title":"J Inherit Metab Dis"},{"key":"4111_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","volume":"40","author":"K Trpkov","year":"2016","unstructured":"Trpkov K, Hes O, Agaimy A et al (2016) Fumarate hydratase\u2013deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol 40:865\u2013875. https:\/\/doi.org\/10.1097\/PAS.0000000000000617","journal-title":"Am J Surg Pathol"},{"key":"4111_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.humpath.2022.12.013","volume":"134","author":"R Mannan","year":"2023","unstructured":"Mannan R, Wang X, Bawa PS et al (2023) Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma. Hum Pathol 134:102\u2013113. https:\/\/doi.org\/10.1016\/j.humpath.2022.12.013","journal-title":"Hum Pathol"},{"key":"4111_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.5858\/arpa.2018-0216-RA","volume":"142","author":"SL Skala","year":"2018","unstructured":"Skala SL, Dhanasekaran SM, Mehra R (2018) Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): a contemporary review and practical discussion of the differential diagnosis for HLRCC-associated renal cell carcinoma. Arch Pathol Lab Med 142:1202\u20131215. https:\/\/doi.org\/10.5858\/arpa.2018-0216-RA","journal-title":"Arch Pathol Lab Med"},{"key":"4111_CR37","doi-asserted-by":"publisher","first-page":"151599","DOI":"10.1016\/j.anndiagpath.2020.151599","volume":"49","author":"N Kuroda","year":"2020","unstructured":"Kuroda N, Tsutsui M, Iguchi M et al (2020) Fumarate hydratase-deficient renal cell carcinoma: a clinicopathological study of seven cases including hereditary and sporadic forms. Ann Diagn Pathol 49:151599. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151599","journal-title":"Ann Diagn Pathol"},{"key":"4111_CR38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/his.14816","volume":"82","author":"SR Williamson","year":"2023","unstructured":"Williamson SR, Hes O, Trpkov K et al (2023) Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity. Histopathology 82:296\u2013304. https:\/\/doi.org\/10.1111\/his.14816","journal-title":"Histopathology"},{"key":"4111_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-023-03673-9","volume":"483","author":"C Ricci","year":"2023","unstructured":"Ricci C, Ambrosi F, Franceschini T et al (2023) Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT. Virchows Arch 483:687\u2013698. https:\/\/doi.org\/10.1007\/s00428-023-03673-9","journal-title":"Virchows Arch"},{"key":"4111_CR40","doi-asserted-by":"publisher","first-page":"1610852","DOI":"10.3389\/pore.2023.1610852","volume":"29","author":"T Chen","year":"2023","unstructured":"Chen T, Peng Y, Lei T et al (2023) Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations. Pathol Oncol Res 29:1610852. https:\/\/doi.org\/10.3389\/pore.2023.1610852","journal-title":"Pathol Oncol Res"},{"key":"4111_CR41","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.5858\/2007-131-1782-VRIROI","volume":"131","author":"O Hes","year":"2007","unstructured":"Hes O, Michal M, Kuroda N et al (2007) Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases. Arch Pathol Lab Med 131:1782\u20131788. https:\/\/doi.org\/10.5858\/2007-131-1782-VRIROI","journal-title":"Arch Pathol Lab Med"},{"key":"4111_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2559.2011.03753.x","volume":"58","author":"JC Carvalho","year":"2011","unstructured":"Carvalho JC, Wasco MJ, Kunju LP et al (2011) Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Histopathology 58:169\u2013179. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03753.x","journal-title":"Histopathology"},{"key":"4111_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1365-2559.2010.03726.x","volume":"57","author":"K Trpkov","year":"2010","unstructured":"Trpkov K, Yilmaz A, Uzer D et al (2010) Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features. Histopathology 57:893\u2013906. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03726.x","journal-title":"Histopathology"},{"key":"4111_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-199701000-00001","volume":"21","author":"MB Amin","year":"1997","unstructured":"Amin MB, Crotty TB, Tickoo SK, Farrow GM (1997) Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21:1\u201312. https:\/\/doi.org\/10.1097\/00000478-199701000-00001","journal-title":"Am J Surg Pathol"},{"key":"4111_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","volume":"40","author":"WJ Harrison","year":"2016","unstructured":"Harrison WJ, Andrici J, Maclean F et al (2016) Fumarate hydratase\u2013deficient uterine leiomyomas occur in both the syndromic and sporadic settings. Am J Surg Pathol 40:599\u2013607. https:\/\/doi.org\/10.1097\/PAS.0000000000000573","journal-title":"Am J Surg Pathol"},{"key":"4111_CR46","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","volume":"40","author":"M Miettinen","year":"2016","unstructured":"Miettinen M, Felisiak-Golabek A, Wasag B et al (2016) Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases. Am J Surg Pathol 40:1661\u20131669. https:\/\/doi.org\/10.1097\/PAS.0000000000000703","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04111-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04111-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04111-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T02:19:24Z","timestamp":1756347564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04111-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4111"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04111-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}